Updated AIDSinfo Drug Database Offers Health Professionals and Patients the Latest HIV-Related Drug Information

The latest additions to the AIDSinfo drug database provide health care providers and patients with even more information on HIV/AIDS-related drugs.   Recent improvements to the database include: Investigational HIV drug summaries for health professionals that include the most recent information on pharmacology, dosing, adverse events, and drug interactions. The drug summaries also feature drug compound details from ChemIDplus Advanced (United States National Library of Medicine) and the HIV Drugs in Development Database from the National Institute of Allergy and Infectious Diseases (NIAID). Updated HIV investigational drug summaries for patients that highlight the latest research on HIV-related drugs under investigation. Updated and new opportunistic infection drug summaries for health professionals and patients that reflect the latest information in the recently released (May 7, 2013) Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents. The updated information includes new drug summaries for boceprevir (brand name: Victrelis), telaprevir (brand name: Incivek), and hepatitis A and hepatitis B (recombinant) vaccine (brand name: Twinrix).  Future additions to the drug database will include more investigational HIV drug summaries for health professionals and patients, as well as Spanish versions of all updated and new patient drug summaries.   Please forward feedback on the AIDSinfo drug data...